9 Meters Biopharma Inc.

NASDAQ: NMTR · Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM

9 Meters Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-13.87M -11.93M -9.35M -11.13M -11.35M -9.55M -13.54M -8.25M -5.43M
Depreciation & Amortization
1.33K 2.54K 1.57K 2.79K 1.63K 2.92K 1.33K 2.22K 1.11K
Stock-Based Compensation
737K 744K 730K 1.77M 690K 529K 525K 937K 422K
Other Working Capital
822.04K -3.16M -881.87K 652.77K 1.43M -65.67K 2.19M 190.17K -1.14M
Other Non-Cash Items
1.07M 991.9K 423.35K 500K n/a n/a 2.61M n/a 36.98K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a -7K
Change in Working Capital
2.31M 452.85K -1.77M 1.07M 911.78K 1.05M 2.23M 205.07K -1.25M
Operating Cash Flow
-9.75M -9.74M -9.97M -7.79M -9.75M -7.97M -8.17M -7.11M -6.22M
Capital Expenditures
n/a -2.84K n/a n/a -2.84K -2.63K -2.5M -1.88K -5.01K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -2.42M n/a n/a
Investing Cash Flow
n/a -2.84K n/a n/a -2.84K -2.63K -2.42M -1.88K -5.01K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-12.29M 1.09M 19.91M n/a n/a 1.36M 180.03K 32.64M 6.87M
Financial Cash Flow
-12.29M -2.18M 19.91M n/a n/a 1.36M 180.03K 32.64M 6.87M
Net Cash Flow
-22.04M -9.74M 9.94M -7.79M -9.75M -6.62M -10.41M 25.53M 644.72K
Free Cash Flow
-9.75M -9.74M -9.97M -7.79M -9.75M -7.97M -10.67M -7.11M -6.23M